基本信息
浏览量:190
职业迁徙
个人简介
I am interested in developing new strategies for the treatment of acute myeloid leukemia (AML). Our new AML protocol (AML08) will determine if the combination of clofarabine and cytarabine is as effective as standard induction with cytarabine, daunomycin, and etoposide; and will test whether the infusion of haploidentical natural killer cells can reduce relapse rates. We will also explore novel therapies for certain high risk groups and continue our studies of minimal residual disease and genome-wide analysis in AML.
研究兴趣
论文共 384 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Haematologicano. 3 (2024): 994-999
CANCER MEDICINEno. 7 (2024): e6966-e6966
CANCER MEDICINEno. 3 (2024): e6842-e6842
Jennifer L. Kamens,Stephanie Nance,Cary Koss,Beisi Xu,Anitria Cotton, Jeannie W. Lam,Elizabeth A. R. Garfinkle,Pratima Nallagatla, Amelia M. R. Smith,Sharnise Mitchell,Jing Ma,Duane Currier,
NATURE COMMUNICATIONSno. 1 (2023)
引用1浏览0引用
1
0
Lu Wang, Victor Pastor Loyola,Scott Foy,Maria Cardenas,Jamie Maciaszek,Priyadarshini Kumar,Alexander Gout,Gout Mark Wilkinson, Jennifer Neary,Zonggao Shi,David Wheeler,Jeffrey Rubnitz,
引用0浏览0引用
0
0
Branko Cuglievan, David Dickens,Shalini Shenoy,Jeffrey Rubnitz,Raul Ribeiro, Andrew Place,Naval Daver, Irina Zaidman, Pinki Prasad, Nicole McNeer, Yu Gu, Soujanya Sunkaraneni,
PEDIATRIC BLOOD & CANCER (2023): S47-S48
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn